HCID 69320502, Verbindung → HCID 11313604, Verbindung
Reaktionsgleichung
[CH:1]1([N:6]2[C:10]3[N:11]=[CH:12][N:13]=[C:14]([NH2:15])[C:9]=3[C:8]([C:16]3[NH:20][C:19]4[CH:21]=[C:22]([N+:25]([O-])=O)[CH:23]=[CH:24][C:18]=4[N:17]=3)=[CH:7]2)[CH2:5][CH2:4][CH2:3][CH2:2]1.[H][H]>[Pd].CN1C(=O)CCC1>[NH2:25][C:22]1[CH:23]=[CH:24][C:18]2[N:17]=[C:16]([C:8]3[C:9]4[C:14]([NH2:15])=[N:13][CH:12]=[N:11][C:10]=4[N:6]([CH:1]4[CH2:5][CH2:4][CH2:3][CH2:2]4)[CH:7]=3)[NH:20][C:19]=2[CH:21]=1Komponenten
5
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Versuchsvorschrift
7-Cyclopentyl-5-(6-nitro-1H-benzoimidazol-2-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-ylamine (1E, 1.0 g) was combined with 10% Palladium on carbon (100 mg) in 50 mL of anhydrous NMP and subjected to 50 psi of hydrogen at room temperature for 24 hours. LCMS monitor suggested pure desired product (M/Z 333.5, retention time 0.70 min. with analytical HPLC method 4). The mixture was filtered through celite. Desired product was used as an NMP stock solution (concentration of about 0.92 g in 45 mL).
Quellen und Nachweise
- ORD-Eintrag
- ord-373af516af974060a6ac8d4d532569a7
- Quelldatensatz
- uspto-grants-2008_10
- Patentnummer
- US07435739B2
Notizen zur Reaktion
Wird geladen…